hydrogen sulphide-releasing derivative of naproxen (ATB-346) - Antibe
https://www.businesswire.com/news/home/20191128005222/en/Antibe-Therapeutics-Corporate-Update-Reports-Q2-2020
 
Nov 28, 2019
 
Prev Next